首页>外文期刊>医学、药学、卫生>内科学>Therapeutic advances in hematology.

Therapeutic advances in hematology.

中文名称：血液学的治疗进展。

ISSN：2040-6207
出版周期：-

发文量：328

期刊论文

热门论文

年度选择

2021
- 第a期
2020
- 第11期
- 第12期
2019
- 第1期
- 第10期
- 第11期
- 第12期
2018
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2017
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2016
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2015
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2014
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2013
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2012
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2011
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2010
- 第1期

更多>>

全选（0）

1.Seasonal variation of immunethrombocytopenic purpura relatedhospitalizations among adults in the USA:analysis of the nationwide inpatient sampledatabase

机译：美国成年人免疫性血小板减少性紫癜相关住院的季节性变化：全国住院样本数据库的分析
- 作者：Smith Giri;Ranjan Pathak;Madan R. Aryal;Paras Karmacharya;Vijaya R. Bhatt;Mike G. Martin
- 期刊名称：《Therapeutic advances in hematology.》 | 2015年第4期
2.Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence

机译：溴结构域和末端外蛋白（BET）的抑制作为血液系统恶性肿瘤的潜在治疗方法：新兴的临床前和临床证据
- 作者：Aristeidis Chaidos;Valentina Caputo Anastasios Karadimitris
- 期刊名称：《Therapeutic advances in hematology.》 | 2015年第3期
- acetylation;
- acute leukaemia;
- benzodiazepines;
- BET proteins;
- bromodomains;
- lymphoma;
- multiple myeloma;
- MYC;
3.Current challenges and novel treatment strategies in double hit lymphomas

机译：双重淋巴瘤的当前挑战和新颖的治疗策略
- 作者：Mary Ann Anderson;Alpha Tsui;Meaghan Wall;David C. S. Huang Andrew W. Roberts
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第1期
- BCL-2;
- diffuse large B-cell lymphoma;
- double hit lymphoma;
- MYC;
4.Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia

机译：降低强度的同种异体造血细胞移植治疗老年急性髓细胞白血病患者
- 作者：Gaurav Goyal;Krishna Gundabolu;Saraschra Vallabhajosyula;Peter T. Silberstein;Vijaya Raj Bhatt
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第3期
5.Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential

机译：Mogamulizumab治疗皮肤T细胞淋巴瘤：最新进展和临床潜力
- 作者：Madeleine Duvic;Mark Evans;Casey Wang
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第3期
- cutaneous T-cell lymphoma;
- mogamulizumab;
- peripheral T-cell lymphoma;
6.Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab

机译：免疫刺激性SLAMF7抗体依洛珠单抗治疗多发性骨髓瘤
- 作者：Hermann Einsele;Martin Schreder
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第5期
- antibody-based immunotherapy;
- CS1;
- elotuzumab;
- multiple myeloma;
- SLAMF7;
7.H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes

机译：生命值。 Acthar Gel（促肾上腺皮质激素注射液）治疗多发性硬化症和糖尿病患者
- 作者：Christen Kutz
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第4期
- Acthar Gel;
- blood glucose;
- diabetes mellitus;
- hyperglycemia;
- multiple sclerosis;
- steroids;
8.Ustekinumab in Crohn's disease: evidence to date and place in therapy

机译：Ustekinumab在克罗恩病中的作用：迄今为止的证据和治疗证据
- 作者：Tal Engel;Uri Kopylov
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第4期
- Crohn's disease;
- interleukin 12/23p40 inhibitor;
- ustekinumab;
9.Obinutuzumab for relapsed or refractory indolent non-Hodgkin's lymphomas

机译：奥比妥珠单抗用于复发性或难治性惰性非霍奇金淋巴瘤
- 作者：Ludovic Gabellier Guillaume Cartron
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第2期
10.The potential of venetoclax (ABT-199) in hronic lymphocytic leukemia

机译：Venetoclax（ABT-199）在慢性淋巴细胞性白血病中的潜力
- 作者：Gilad Itchaki;Jennifer R. Brown
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第5期
- ABT-199;
- B-cell chronic lymphocytic leukemia;
- venetoclax;
11.Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence

机译：针对急性髓性白血病中的白血病-基质相互作用：原理和最新证据
- 作者：Arm in Rashidi John F. DiPersio
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第1期
- leukemia;
- microenvironment;
- niche;
- stem cell;
- stroma;
- therapeutics;
12.The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challenges

机译：基因疗法治疗血红蛋白病的潜力：成就和挑战
- 作者：Michael A. Goodman;Punam Malik
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第5期
- gene editing;
- gene therapy;
- hemoglobin;
- hemoglobinopathy;
- sickle cell anemia;
- thalassemia;
13.The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

机译：blinatumomab在复发/难治性急性淋巴细胞白血病患者中的作用
- 作者：Jonathan E. Benjamin;Anthony S. Stein
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第3期
- B-acute lymphoblastic leukemia;
- blinatumomab;
- relapsed/refractory;
14.The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia

机译：艾达拉西布在复发性和难治性慢性淋巴细胞性白血病治疗中的作用
- 作者：Kruti Sheth Nair Bruce Cheson
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第2期
15.Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies

机译：监测急性髓细胞性白血病的最小残留病：当前发展战略的回顾
- 作者：Hans Beier Ommen
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第1期
- Minimal residual disease;
- Preemotive treatment;
- AML;
- flow cytometry;
- qPCR;
- NGS;
16.Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)

机译：新型免疫疗法用于治疗急性白血病（髓样和淋巴母细胞）
- 作者：Kazusa Ishii Austin J. Barrett
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第1期
- immune-editing;
- leukemia;
- immunotherapy;
17.Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib

机译：靶向慢性淋巴细胞性白血病中的B细胞受体信号激酶：恩妥司替尼的前景
- 作者：Jeff Sharman;Julie Di Paolo
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第3期
18.Recent advances and novel treatment paradigms in acute lymphocytic leukemia

机译：急性淋巴细胞白血病的最新进展和新的治疗方法
- 作者：Nikolaos Papadantonakis;Anjali S. Advani
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第5期
- blinatumomab;
- chimeric antigen receptor;
- immunoconjugates;
- immunotherapy;
- notuzumab;
- leukemia;
- relapsed/refractory;
19.Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy

机译：富马酸二甲酯在多发性硬化症中的最新进展，证据和治疗方法
- 作者：Ralf A. Linker;Aiden Haghikia
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第4期
- clinical practice;
- dimethyl fumarate;
- multiple sclerosis;
20.Current developments in molecular monitoring in chronic myeloid leukemia

机译：慢性粒细胞白血病分子监测的最新进展
- 作者：Justine Ellen Marum;Susan Branford
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第5期
- chronic myeloid leukemia;
- molecular monitoring;
- BCR-ABL1;
- resistance mutations;
- minimal residual disease;
- qRT-PCR;
- Next-generation sequencing;
- digital PCR;
21.Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia

机译：慢性淋巴细胞白血病患者一线使用依鲁替尼的经验
- 作者：Gilad Itchaki;Jennifer R. Brown
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第1期
- chronic lymphocytic leukemiaibrutinibfirst-line;
22.Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?

机译：急性髓细胞白血病嵌合抗原受体T细胞免疫疗法：我们走了多远？
- 作者：Sarah K Tasian
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第6期
- acute myeloid leukemiachimeric antigen receptorclinical trialcytokine release syndromeimmunotherapyT cell;
23.Update on the role of brentuximab vedotin in classical Hodgkin lymphoma

机译：布伦妥昔单抗维他汀在经典霍奇金淋巴瘤中的作用的最新进展
- 作者：Sarah Tomassetti;Alex F. Herrera
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第9期
- Brentuximab vedotinHodgkin lymphoma;
24.Practical aspects of extended half-life products for the treatment of haemophilia

机译：延长半衰期产品治疗血友病的实践方面
- 作者：Thierry Lambert;Gary Benson;Gerry Dolan;Cedric Hermans;Victor Jiménez-Yuste;Rolf Ljung;Massimo Morfini;Silva Zupan?i?-?alek;Elena Santagostino
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第9期
- extended half-life productsfactor VIIIfactor IXhaemophiliapractical considerationsprophylaxis;
25.The role of stem cell transplantation in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia

机译：干细胞移植在费城染色体阳性急性淋巴细胞白血病中的作用
- 作者：Jose-Maria Ribera;Jordi Ribera;Eulalia Genescà
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第12期
- acute lymphoblastic leukemiaallogeneicautologousPhiladelphia chromosomestem cell transplantation;
26.Novel treatment approaches and future perspectives in follicular lymphoma

机译：滤泡性淋巴瘤的新治疗方法和未来展望
- 作者：Grerk Sutamtewagul;Brian K. Link
- 期刊名称：《Therapeutic advances in hematology.》 | 2019年第10期
- antibody–drug conjugateanti-CD20 antibodyBCL2 inhibitorBTK inhibitorEZH2 inhibitorfollicular lymphomaimmune checkpoint inhibitorPI3K inhibitorradioimmunotherapySYK inhibitor;
27.Immunotherapy in myeloma: how far have we come?

机译：骨髓瘤的免疫治疗：我们走了多远？
- 作者：Laurens E. Franssen;Tuna Mutis;Henk M. Lokhorst;Niels W. C. J. van de Donk
- 期刊名称：《Therapeutic advances in hematology.》 | 2019年第10期
- multiple myelomaimmunotherapyIMiDsbispecific antibodiesCAR-T cellscheckpoint inhibitorsmonoclonal antibodies;
28.Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

机译：FLT3抑制剂在急性髓细胞白血病中的新兴治疗范例
- 作者：Nicholas J. Short;Hagop Kantarjian;Farhad Ravandi;Naval Daver
- 期刊名称：《Therapeutic advances in hematology.》 | 2019年第10期
- acute myeloid leukemiaFLT3gilteritinibmidostaurinquizartinibresistancesorafenibtyrosine kinase inhibitors;
29.Epigenetic therapy combinations in acute myeloid leukemia: what are the options?

机译：表观遗传疗法在急性髓性白血病中的组合：有哪些选择？
- 作者：Jan Philipp Bewersdorf;Rory Shallis;Maximilian Stahl;Amer M. Zeidan
- 期刊名称：《Therapeutic advances in hematology.》 | 2019年第10期
- acute myelogenous leukemiaacute myeloid leukemiaAMLcombination therapyDNA methylationepigenetic therapyhistoneshistone deacetylase inhibitorshypomethylating agent;
30.A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting

机译：在美国社区肿瘤学中对卡非佐米和其他系统性多发性骨髓瘤化疗的真实比较分析
- 作者：Robert M. Rifkin;Rohan Medhekar;E. Susan Amirian;Kathleen M. Aguilar;Thomas Wilson;Marley Boyd;Khalid Mezzi;Sumeet Panjabi
- 期刊名称：《Therapeutic advances in hematology.》 | 2019年第10期
- carfilzomibcomparative effectivenessmultiple myelomarelapsesecond-line of therapy;
31.Recent advances and novel treatment paradigms in acute lymphocytic leukemia

机译：急性淋巴细胞白血病的最新进展和新的治疗方法
- 作者：Nikolaos Papadantonakis;Anjali S. Advani
- 期刊名称：《Therapeutic advances in hematology.》 | 2016年第5期
- blinatumomabchimeric antigen receptorimmunoconjugatesimmunotherapyinotuzumableukemiarelapsed/refractory;
32.Emerging role of checkpoint blockade therapy in lymphoma

机译：检查点封锁疗法在淋巴瘤中的新兴作用
- 作者：Natalie Galanina;Justin Kline;Michael R. Bishop
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第2期
- checkpointcheckpoint blockadecytotoxic T-lymphocyte-associated protein 4immunotherapylymphomaprogrammed death 1programmed death ligand 1/2;
33.Point-of-care ultrasonography (POCUS) in hemophilia A: a commentary on current status and its potential role for improving prophylaxis management in severe hemophilia A

机译：甲型血友病的即时护理超声检查（POCUS）：对当前状态及其对改善甲型严重血友病预防管理的潜在作用的评论
- 作者：Suchitra S. Acharya;Brittny Rule;Omar McMillan;Thomas J. Humphries
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第4期
- adherencearthropathyhemophiliamagnetic resonance imagingprophylaxisultrasonography;
34.From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag

机译：从慢性免疫性血小板减少症到严重再生障碍性贫血：最近对eltrombopag演变的见解
- 作者：Harinder Gill;Raymond S. M. Wong;Yok-Lam Kwong
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第5期
- acute myeloid leukemiaeltrombopaghematopoietic stem cell transplantationhepatitis C virusimmune thrombocytopeniamyelodysplastic syndromesevere aplastic anemia;
35.Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab

机译：针对霍奇金淋巴瘤中的程序性细胞死亡1途径：nivolumab的位置
- 作者：Nathan D. Gay;Craig Y. Okada;Andy I. Chen;Emma C. Scott
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第5期
- checkpoint inhibitorHodgkin lymphomaimmunotherapynivolumabprogrammed cell death 1programmed cell death-ligand 1programmed cell death-ligand 2;
36.Red cell genotyping precision medicine: a conference summary

机译：红细胞基因分型精准医学：会议摘要
- 作者：Gregory A. Denomme;Waseem Q. Anani;Neil D. Avent;Gregor Bein;Lynne B. Briggs;Razvan C. Lapadat;Celina Montemayor;Maria Rios;Maryse St-Louis;Lynne Uhl;Silvano Wendel;Willy A. Flegel
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第10期
- red cell genotypingmolecular immunohematologytransfusion precision medicine;
37.Current and emerging factor VIII replacement products for hemophilia A

机译：当前和新兴的A型血友病因子VIII替代产品
- 作者：Lorraine A. Cafuir;Christine L. Kempton
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第10期
- extended half-life FVIIIfactor VIIIgene therapyhemophilia Ainhibitororthologpolyethylene glycol (PEG)replacement products;
38.Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma

机译：与典型结节性硬化性霍奇金淋巴瘤相比，合胞体变异霍奇金淋巴瘤患者的预后差异
- 作者：Tarsheen Sethi;Van Nguyen;Shaoying Li;David Morgan;John Greer;Nishitha Reddy
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第1期
- Hodgkin lymphomanodular sclerosisoutcomesyncytial variant;
39.Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma

机译：复发性低度非霍奇金淋巴瘤患者体外放射线启动放射免疫治疗
- 作者：Yazan Abuodeh;Kamran Ahmed;Michelle Echevarria;Arash Naghavi;G. Daniel Grass;Timothy J. Robinson;Michael Tomblyn;Bijal Shah;Julio Chavez;Celeste Bello;Ghassan El-Haddad;Louis Harrison;Sungjune Kim
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第4期
- CD20non-Hodgkin lymphomaradioimmunotherapy;
40.Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update

机译：Radotinib及其在慢性慢性粒细胞白血病患者中的临床潜力：最新进展
- 作者：Ahmet Emre Eskazan;Dilek Keskin
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第9期
- bosutinibchronic myeloid leukemiadasatinibimatinibnilotinibponatinibradotinibtyrosine kinase inhibitor;
41.An update on the role of daratumumab in the treatment of multiple myeloma

机译：daratumumab在多发性骨髓瘤治疗中的作用的最新进展
- 作者：Caitlin Costello
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第1期
- daratumumabmonoclonal antibodymultiple myeloma;
42.Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease

机译：骨髓增生性肿瘤的内脏静脉血栓形成：疾病的病理生理和分子机制
- 作者：Joan How;Amy Zhou;Stephen T. Oh
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第3期
- Budd-Chiari syndromeessential thrombocythemiaJAK2myeloproliferative neoplasmpolycythemia veraportal vein thrombosisprimary myelofibrosissplanchnic vein thrombosis;
43.Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician’s guide

机译：阵发性夜间血红蛋白尿的血栓形成管理：临床指南
- 作者：Morag Griffin;Talha Munir
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第3期
- haemoglobinuriahaemolytic anaemiaparoxysmal nocturnalthrombosisultra-orphan disease;
44.Experience with ruxolitinib in the treatment of polycythaemia vera

机译：鲁索替尼治疗真性红细胞增多症的经验
- 作者：Samah Alimam;Claire Harrison
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第4期
- polycythaemia veraruxolitinibtreatment resistance;
45.Biological and clinical implications of telomere dysfunction in myeloid malignancies

机译：骨髓恶性肿瘤中端粒功能障碍的生物学和临床意义
- 作者：Ashwin Kishtagari;Justin Watts
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第11期
- acute myeloid leukemiamyeloid malignanciestelomerasetelomerase inhibitorstelomerestelomere length;
46.Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma

机译：当前治疗复发性霍奇金淋巴瘤的策略
- 作者：Liana Nikolaenko;Robert Chen;Alex F. Herrera
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第10期
- relapsed Hodgkin lymphoma;
47.Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

机译：阿扎胞苷对中老年高危骨髓增生异常综合症患者的安全性和有效性
- 作者：Shyamala C. Navada;Lewis R. Silverman
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第1期
- adverse drug eventazacitidineelderlyhigher-risk diseasemyelodysplastic syndromessafetysurvival;
48.New monoclonal antibodies on the horizon in multiple myeloma

机译：多发性骨髓瘤中新的单克隆抗体即将出现
- 作者：Elizabeth K. O’Donnell;Noopur S. Raje
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第2期
- monoclonal antibodiesmultiple myelomanovel therapies;
49.Sweet’s syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine

机译：甜味综合征与对5-氮杂胞苷有反应的潜在不确定性克隆性造血相关
- 作者：George Yaghmour;Eric Wiedower;Bassam Yaghmour;Sara Nunnery;Eric Duncavage;Mike G. Martin
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第2期
- Sweet’s syndromeCHIPVidaza;
50.Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review

机译：苯达莫司汀及其在不适合的慢性淋巴细胞性白血病患者中的作用
- 作者：Othman Al-Sawaf;Paula Cramer;Valentin Goede;Michael Hallek;Natali Pflug
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第6期
- bendamustinechronic lymphocytic leukaemiaelderly patients;
51.The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma

机译：第二代蛋白酶体抑制剂ixazomib在治疗多发性骨髓瘤中的潜力
- 作者：Jason Brayer;Rachid Baz
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第7期
- multiple myelomaixazomibproteasome inhibitor;
52.Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A

机译：成人获得性A型血友病的重组抗血友病猪序列因子VIII的综述
- 作者：Emma Fosbury;Anja Drebes;Anne Riddell;Pratima Chowdary
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第9期
- acquired haemophiliabypassing agentsporcine factor VIII;
53.Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib

机译：对伊马替尼反应欠佳的18例慢性期慢性粒细胞白血病患者改用尼罗替尼的影响的探索性研究
- 作者：Sikander Ailawadhi;Luke P. Akard;Carole B. Miller;Anand Jillella;Daniel J. DeAngelo;Solveig G. Ericson;Felice Lin;Ghulam Warsi;Jerald Radich
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第1期
- CML-CPENABLimatinibnilotinibsuboptimal responseswitchtyrosine kinase inhibitor;
54.Optimizing current and emerging therapies in multiple myeloma: a guide for the hematologist

机译：优化多发性骨髓瘤的当前和新兴疗法：血液科医生指南
- 作者：Shahzad Raza;Rachael A. Safyan;Evan Rosenbaum;Alex S. Bowman;Suzanne Lentzsch
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第2期
- immunomodulatormultiple myelomanovel treatment optionsproteasome inhibitor;
55.Maintenance therapy in multiple myeloma

机译：多发性骨髓瘤的维持治疗
- 作者：Prerna Mewawalla;Abhishek Chilkulwar
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第2期
- multiple myelomamaintenanceautologous stem cell transplantbortezomiblenalidomide;
56.The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies

机译：氟达拉滨，环磷酰胺和利妥昔单抗化学免疫疗法联合在慢性淋巴细胞性白血病中的作用：当前证据和争议
- 作者：Alan P. Skarbnik;Stefan Faderl
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第3期
- chemoimmunotherapyCLLFCRfludarabinerituximab;
57.Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape

机译：Vosaroxin在复发/难治性急性髓性白血病中的作用：在当前治疗范围内的有效性和安全性
- 作者：Valeriy Sedov;Robert K. Stuart
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第6期
- acute myelogenous leukemiaacute myeloid leukemiaAMLvosaroxin;
58.Current and emerging treatment options for mantle cell lymphoma

机译：幔细胞淋巴瘤的当前和新兴治疗选择
- 作者：Bita Fakhri;Brad Kahl
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第8期
- mantle cell lymphomastandard therapynovel agents;
59.Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis

机译：Midostaurin：FLT3突变的急性髓细胞性白血病和全身性肥大细胞增多症患者的新型治疗药物
- 作者：Molly M. Gallogly;Hillard M. Lazarus;Brenda W. Cooper
- 期刊名称：《Therapeutic advances in hematology.》 | 2017年第9期
- acute myeloid leukemiaallogeneic transplantclinical trialsFLT3 mutationmidostaurinsystemic mastocytosis;
60.The evolution of stem-cell transplantation in multiple myeloma

机译：多发性骨髓瘤干细胞移植的演变
- 作者：Sarakshi Mahajan;Nidhi Tandon;Shaji Kumar
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第5期
- allogenicautologousmultiple myelomastem-cell transplant;
61.The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia

机译：依那sideb在治疗突变型IDH2急性髓性白血病中的作用
- 作者：Iman Abou Dalle;Courtney D. DiNardo
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第7期
- acute myeloid leukemiaenasidenibisocitrate dehydrogenase 2refractoryrelapsed;
62.A case series of Kimura’s disease: a diagnostic challenge

机译：木村病的病例系列：诊断挑战
- 作者：Vivek Kumar;Navneet Mittal;Yiwu Huang;Jasminka Balderracchi;Huo Xiang Zheng;Zujin Li;Yiqing Xu
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第7期
- eosinophiliaHodgkin’s lymphomaimmunoglobulin EKimura’s disease;
63.The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A

机译：艾米珠单抗（一种双特异性因子IXa和X因子定向抗体）在预防A型血友病患者出血事件中的作用
- 作者：Tristan Knight;Michael U. Callaghan
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第10期
- ACE910 (M000618665)antibodiesbispecific (D12.776.124.486.485.114.125)emicizumab (C000608208)factor VIII (D12.776.124.125.350)hemophilia A (C15.378.100.100.500);
64.Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility

机译：派姆单抗及其在复发/难治性经典霍奇金淋巴瘤中的作用：迄今为止的证据和临床应用
- 作者：Polina Shindiapina;Lapo Alinari
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第4期
- checkpoint inhibitor therapyHodgkin’s lymphomapembrolizumab;
65.Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice

机译：个性化急性髓细胞性白血病的初始治疗：将新药纳入临床实践
- 作者：Christin B. DeStefano;Christopher S. Hourigan
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第5期
- acute myeloid leukemianovel agentspersonalized therapy;
66.Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia

机译：基于药代动力学的延长半衰期凝血因子实际给药剂量的预测集中于血友病
- 作者：Massimo Morfini;Stefano Gherardini
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第6期
- ABRFVIII/IX efficacyFVIII/IX extended half-lifeFVIII/IX tailoringimmunogenicitypharmacokineticspharmacodynamicsswitchvenous access;
67.Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant

机译：利用异基因造血干细胞移植在骨髓纤维化中利用JAK-STAT调节来改善预后
- 作者：Michael Byrne;Bipin Savani;Michael R. Savona
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第9期
- myelofibrosisallogeneictransplantationrelapse;
68.Novel therapies and current clinical progress in hemophilia A

机译：A型血友病的新疗法和当前临床进展
- 作者：Pauline Balkaransingh;Guy Young
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第2期
- anticoagulation inhibitionbispecific antibodyextended half lifegene therapyhemophilia Anovel therapies;
69.Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study

机译：尼洛替尼在对伊马替尼有耐药性或不耐受的慢性或加速期慢性髓样白血病患者的常规临床实践中的安全性和有效性：来自NOVEL研究的结果
- 作者：Ching-Yuan Kuo;Po-Nan Wang;Wen-Li Hwang;Cheng-Hwai Tzeng;Li-Yaun Bai;Jih-Luh Tang;Ming-Chih Chang;Sheng-Fung Lin;Tsai-Yun Chen;Yeu-Chin Chen;Tran-Der Tan;Chih-Yi Hsieh;Chinjune Lin;Clinton Lai;Darko Miljkovic;Cheng-Shyong Chang
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第3期
- chronic myeloid leukemiaclinical trialimatinib-resistantnilotinib;
70.BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review

机译：BAY 81-8973，用于治疗血友病A的全长重组因子VIII：产品评论
- 作者：Johnny N. Mahlangu;Sanjay P. Ahuja;Jerzy Windyga;Nikki Church;Anita Shah;Lawrence Schwartz
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第7期
- BAY 81-8973hemophilia AKovaltrypharmacokineticsprophylaxisrecombinant factor VIII;
71.Gene therapy for hemophilia: what does the future hold?

机译：血友病的基因治疗：未来会怎样？
- 作者：Bhavya S. Doshi;Valder R. Arruda
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第9期
- adeno-associated virusgene therapyhemophilialentivirus;
72.Clinicopathological parameters influencing inhibitor development in patients with hemophilia A receiving on-demand therapy

机译：甲型血友病按需治疗影响抑制剂发展的临床病理参数
- 作者：Sanya Arshad;Anshima Singh;Namrata Punit Awasthi;Swati Kumari;Nuzhat Husain
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第8期
- hemophilia Afactor VIIIinhibitorsBethesda assayplasma derived factor VIII;
73.The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries

机译：在发达国家和发展中国家，在新的血友病治疗时代，患者和医护人员的作用
- 作者：Fadi Nossair;Courtney D. Thornburg
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第8期
- clotting factorextended half-lifegene therapyhemophilianovel therapiesshared decision making;
74.Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

机译：伊诺单抗ozogamicin治疗急性淋巴细胞白血病
- 作者：J. Michael Savoy;Mary Alma Welch;Patrice E. Nasnas;Hagop Kantarjian;Elias Jabbour
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第12期
- Acute lymphoblastic leukemiainotuzumabmonoclonal antibody;
75.Eltrombopag-based combination treatment for immune thrombocytopenia

机译：基于Eltrombopag的组合治疗免疫性血小板减少症
- 作者：David Gómez-Almaguer
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第10期
- immune thrombocytopeniadrug combinationsdrug synergismimmunosuppressive agentseltrombopagromiplostimrituximab;
76.New and emerging therapies for acute and chronic graft versus host disease

机译：急性和慢性移植物抗宿主疾病的新疗法
- 作者：LaQuisa Hill;Amin Alousi;Partow Kebriaei;Rohtesh Mehta;Katayoun Rezvani;Elizabeth Shpall
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第1期
- acute graft versus host diseaseallogeneic stem-cell transplantationchronic graft versus host diseaseGVHD;
77.Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant

机译：MYC和BCL2的共表达预示了复发/难治性弥漫性大B细胞淋巴瘤与R-ICE和移植意图的预后较差
- 作者：Joshua Allen;Ana Lucia Ruano Mendez;Lisa Rybicki;Yazeed Sawalha;Deepa Jagadeesh;Robert Dean;Brad Pohlman;Mitchell R. Smith;Eric D. Hsi;Brian T. Hill
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第4期
- clinical resultslymphomapharmacotherapeuticsprognostication;
78.Update on the role of lenalidomide in patients with multiple myeloma

机译：来那度胺在多发性骨髓瘤患者中的作用的最新进展
- 作者：Sarah A. Holstein;Vera J. Suman;Philip L. McCarthy
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第7期
- immunomodulatory druglenalidomidemultiple myeloma;
79.Recent advances in musculoskeletal physiotherapy for haemophilia

机译：血友病肌肉骨骼物理治疗的最新进展
- 作者：David Stephensen;Melanie Bladen;Paul McLaughlin
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第8期
- haemophiliaphysiotherapyphysical therapyrehabilitationbleedingarthropathymusculoskeletal;
80.Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B

机译：治疗乙型血友病的延长半衰期重组因子IX产品的临床试验数据更新
- 作者：Johnny N. Mahlangu
- 期刊名称：《Therapeutic advances in hematology.》 | 2018年第11期
- efficacyextended half-lifehaemophilia Bpharmacokineticsrecombinant FIXsafety;
81.Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma

机译：布伦妥昔单抗vedotin在霍奇金淋巴瘤或系统间变性大细胞淋巴瘤患者中的安全性和有效性
- 作者：Christos Vaklavas;Andres Forero-Torres
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第4期
- anaplastic large cell lymphomaantibody-drug conjugatebrentuximab vedotincAC10-vcMMAECD30CD30 targetingHodgkin’s lymphomaSGN-35;
82.Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease

机译：除地雷肽治疗严重肝静脉阻塞性疾病的安全性和有效性
- 作者：Paul G. Richardson;Vincent T. Ho;Sergio Giralt;Sally Arai;Shin Mineishi;Corey Cutler;Joseph H. Antin;Nicole Stavitzski;Dietger Niederwieser;Ernst Holler;Enric Carreras;Robert Soiffer
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第4期
- defibrotidesinusoidal obstruction syndromeveno-occlusive disease;
83.Marginal zone lymphoma: old, new, targeted, and epigenetic therapies

机译：边缘区淋巴瘤：旧的，新的，靶向的和表观遗传学的疗法
- 作者：Monika Joshi;Hassan Sheikh;Kamal Abbi;Sarah Long;Kamal Sharma;Mark Tulchinsky;Elliot Epner
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第5期
- DNA methylationepigeneticsmarginal zone lymphomanon-Hodgkin’s lymphomapurine analogs;
84.Next-generation sequencing in hematologic malignancies: what will be the dividends?

机译：血液恶性肿瘤的下一代测序：将带来什么好处？
- 作者：Jason D. Merker;Anton Valouev;Jason Gotlib
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第6期
- next-generation sequencinghigh-throughput sequencingmassively parallel sequencingsequencing technologiesgenome sequencingexome sequencinghematologic;
85.Azacitidine in the management of patients with myelodysplastic syndromes

机译：阿扎胞苷在骨髓增生异常综合症患者的治疗中
- 作者：Cyrus Khan;Neeta Pathe;Salman Fazal;John Lister;James M. Rossetti
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第6期
- acute myeloid leukemiaazacitidinemethylationmyelodysplastic syndromes;
86.Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma

机译：自体干细胞支持重复清髓性化疗在多发性骨髓瘤中的疗效
- 作者：Helge Menzel;Katarzyna Hinmüller;Hans-Jochem Kolb;Tibor Schuster;Alexander Hoellein;Christian Peschel;Tobias Dechow;Ulrich Keller
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第2期
- high-dose therapymultiple myelomastem-cell transplantation;
87.Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion

机译：来那度胺对5q染色体缺失的骨髓增生异常综合征患者的疗效和安全性
- 作者：Vu H. Duong;Rami S. Komrokji;Alan F. List
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第2期
- deletion 5qlenalidomidemyelodysplastic syndromes;
88.Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myeloma

机译：硼替佐米皮下制剂与常规静脉内制剂治疗多发性骨髓瘤的安全性和有效性
- 作者：Marìa-Victoria Mateos;Jesús F. San Miguel
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第2期
- bortezomibmultiple myelomaintravenous and subcutaneous formulations;
89.Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia

机译：铁螯合剂联合去铁酮治疗输血依赖型地中海贫血的安全性和有效性
- 作者：Saumya S. Jamuar;Angeline H.M. Lai
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第5期
- deferiproneiron chelationiron overloadthalassemia;
90.Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism

机译：口服抗凝治疗的进展：利伐沙班预防和治疗血栓栓塞的安全性和有效性
- 作者：Alexander G.G. Turpie
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第5期
- acute coronary syndromeatrial fibrillationorthopedicspulmonary embolismrivaroxabanstrokevenous thromboembolismvenous thrombosis;
91.Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use

机译：Alemtuzumab在复发性和难治性慢性淋巴细胞性白血病中的使用：未来合理使用的历史和讨论
- 作者：Jeremy L. Warner;Jon E. Arnason
- 期刊名称：《Therapeutic advances in hematology.》 | 2012年第6期
- agammaglobulinaemia tyrosine kinasealemtuzumabB cellCD52 antigenchronicleukemialymphocyticphosphatidylinositol 3 kinaserecurrence;
92.Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions

机译：无血清轻链测定法可检测和监测多发性骨髓瘤及相关疾病
- 作者：Patrizia Tosi;Simona Tomassetti;Anna Merli;Valentina Polli
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第1期
- monoclonal immunoglobulinsmyelomaserum free light chains;
93.Factor VIII inhibitors in hemophilia A: rationale and latest evidence

机译：血友病A中的VIII因子抑制剂：基本原理和最新证据
- 作者：Char Witmer;Guy Young
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第1期
- FVIIIFVIII alloantibodieshemophilia Aimmune toleranceinhibitorsrisk factors;
94.The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update

机译：致癌酪氨酸激酶NPM-ALK的病理生物学：简要更新
- 作者：Raymond Lai;Robert J. Ingham
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第2期
- NPM-ALKSTAT3anaplastic large cell lymphomaoncogenic tyrosine kinasesignalling;
95.Genetic predispositions to childhood leukemia

机译：儿童白血病的遗传易感性
- 作者：Elliot Stieglitz;Mignon L. Loh
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第4期
- genetic predispositiongermlinehematologic malignancyleukemiaoncogenecancer syndrometumor suppressor;
96.Inherited predisposition to multiple myeloma

机译：对多发性骨髓瘤的遗传易感性
- 作者：Divya T. Koura;Amelia A. Langston
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第4期
- autoantigens/geneticsgenetic predisposition to diseasemonoclonal gammopathy of undetermined significance/geneticsmultiple myeloma/epidemiologymultiple myeloma/geneticsparaproteins/geneticsphosphorylation/physiologyrisk factorsWaldenstr?m macroglobulinemia/genetics;
97.Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future

机译：遗传性慢性淋巴细胞白血病的易感性：未来的证据和前景
- 作者：Jennifer R. Brown
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第4期
- CLLcopy number variantfamilialgenomewide association studylinkagemonoclonal B lymphocytosis;
98.Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors

机译：75岁及以上成年人弥漫性大B细胞淋巴瘤：特定病因生存和预后因素的单一机构分析
- 作者：Smith Stephen D.;Chen Andy;Spurgeon Stephen;Okada Craig;Fan Guang;Dunlap Jennifer;Braziel Rita;Maziarz Richard
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第6期
- elderlyDLBCLprognosis;
99.From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma

机译：从临床试验到临床实践：单药卡非佐米不良事件及其在复发和/或难治性多发性骨髓瘤患者中的处理
- 作者：David S. Siegel
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第6期
- carfilzomibdrug toxicitymultiple myelomaproteasome inhibitors;
100.Clofarabine in the treatment of acute myeloid leukemia in older adults

机译：氯法拉滨治疗老年人急性髓细胞性白血病
- 作者：Stephen Tiley;David Claxton
- 期刊名称：《Therapeutic advances in hematology.》 | 2013年第1期
- acute myeloid leukemiaclofarabineolder adults;

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号